Teleperformance SE (TEP)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 80.58 |
|---|---|
| 52-week range | 43.65 – 80.58 |
| Return, 1 month / 3 months | +9.3% / +48.2% |
| Return, 1 year / 3 years | +29.9% / −17.7% |
| Trend | Uptrend |
| RSI (14) | 70 |
| Volatility (1 year) | 47.5% |
| Worst drawdown (1 year) | -35.4% |
| Average daily value traded | 17.28M EUR |
| Dividend yield | 5.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Teleperformance SE is a French provider of outsourced customer experience and business process services. The company runs contact centres and delivers customer care, technical support, back-office processing and related services for clients in sectors such as banking, insurance, healthcare, technology and retail. Its operations span many countries, with staff handling customer interactions by phone, chat, email and other channels on behalf of client organisations. The company is based in France and serves businesses around the world.
The shares are listed on the Euronext Paris in France under the code TEP, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Teleperformance SE (TEP) trades on the Euronext Paris in France. It last closed at EUR 80.58 on 23 October 2026.
Its price-based Market X-Ray is 79 out of 100 (a strong price profile), ranking 25 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.9% and over the last three months it rose 48.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 97 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 37.1% | ||
| From 52-week high | 0.0% | ||
| Momentum | 92 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 48.2% | ||
| 6-month return | 59.7% | ||
| 12-month return, skipping the last month | 18.8% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 47.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.4% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 17.28M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +7.9% |
|---|---|
| 1 month | +9.3% |
| 3 months | +48.2% |
| 6 months | +59.7% |
| 1 year | +29.9% |
| 3 years | −17.7% |
| 5 years | −73.4% |
Signals
| 50-day / 200-day average | 71.56 / 58.79 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2026 | EUR 4.5000 |
| 26 May 2025 | EUR 4.2000 |
| 28 May 2024 | EUR 3.8500 |
| 21 Apr 2023 | EUR 3.8500 |
| 26 Apr 2022 | EUR 3.3000 |
| 27 Apr 2021 | EUR 2.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.